Outlooks on Epstein-Barr virus associated gastric cancer

New research finds Epstein-Barr virus associated gastric cancer (EBVaGC) associated gastric cancer, which comprises approximately 10% of gastric cancer, is a promising biomarker. Published in May 2018’s Cancer Treatment Reviews, “This review provides the most recent updates on molecular pathophysiology, epidemiology, clinical features and treatment advances pertaining to EBVaGC.”